Synapse - Stephen Harnicar

Search Within

Stephen Harnicar

Results (26)

Oncology pharmacy practice in the United States: Results of a comprehensive, nationwide survey

Journal Article

Griffin, S. P.; Signorelli, J. R.; Lasko, A.; Andrick, B. J.; Doan, D.; Hough, S.; Riebandt, G.; Harnicar, S.
Journal of Oncology Pharmacy Practice (2024)

Fulltext@MSK | Save

Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment

Journal Article

Liu, D.; Weintraub, M. A.; Garcia, C.; Goncalves, M. D.; Sisk, A. E.; Casas, A.; Harding, J. J.; Harnicar, S.; Drilon, A.; Jhaveri, K.; more...
Cancer Medicine (2022)

Fulltext@MSK | Save

Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City

Journal Article

Yerram, P.; Thackray, J.; Modelevsky, L. R.; Land, J. D.; Reiss, S. N.; Spatz, K. H.; Levoir, A. C.; Pak, T. K.; Dao, P. H.; Buege, M. J.; more...
Journal of Oncology Pharmacy Practice (2021)

Fulltext@MSK | Save

Entrectinib: An orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors

Journal Article

Liu, D.; Offin, M.; Harnicar, S.; Li, B. T.; Drilon, A.
Therapeutics and Clinical Risk Management (2018)

Fulltext@MSK | Save

Feasibility and toxicity of Pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)

Meeting Abstract

Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S.; Hoover, E.; Chung, D. J.; more...
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with hematopoietic stem cell transplant (HCT) for multiple myeloma (MM), AL amyloidosis (AL), lymphoma, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS)

Meeting Abstract

Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S.; Devlin, S. M.; Castro-Malaspina, H.; Chung, D. J.; more...
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

Integrating clinical pharmacy services into patient care in an early-phase clinical trial clinic

Meeting Abstract

Liu, D.; Dang, T. O.; Harnicar, S.; Kargus, K.; Evans, L. A.; So-Kwan, Y. Y.; Hyman, D. M.
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Feasibility, tolerability, and patient-reported outcomes with pharmacokinetic (PK)-directed dosing of Evomela (propylene glycol free melphalan) for multiple myeloma and AL amyloidosis patients undergoing autologous hematopoietic stem cell transplant (AHCT)

Meeting Abstract

Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S. J.; Hoover, E.; Chung, D. J.; more...
Blood (2017)

Fulltext@MSK | Save

Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with autologous hematopoietic stem cell transplant (AHCT) for multiple myeloma and AL amyloidosis

Meeting Abstract

Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S. J.; Devlin, S. M.; Chung, D. J.; Dahi, P. B.; more...
Blood (2017)

Fulltext@MSK | Save

Rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation and active cancer

Journal Article

Laube, E. S.; Yu, A.; Gupta, D.; Miao, Y.; Samedy, P.; Wills, J.; Harnicar, S.; Soff, G. A.; Mantha, S.
American Journal of Cardiology (2017)

Fulltext@MSK | Save